STRATA CRITICAL MEDICAL, INC. Advertising Expense
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Advertising Expense of $2.71 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2025-03-13
- STRATA CRITICAL MEDICAL, INC. advertising expense for the quarter ending 2022-03-31 was $1.34M, a 158.80% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. advertising expense for the quarter ending 2021-12-31 was $1.02M, a 429.53% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. advertising expense for the quarter ending 2021-09-30 was $796.00K.
- STRATA CRITICAL MEDICAL, INC. advertising expense for the quarter ending 2021-06-30 was $383.00K, a 177.54% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. advertising expense for fiscal 2024 was $2.71M, a 33.22% decline from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. advertising expense for fiscal 2023 was $4.06M, a 10.48% decline from fiscal 2022.
- STRATA CRITICAL MEDICAL, INC. advertising expense for fiscal 2022 was $4.54M, a 140.34% increase from fiscal 2021.
- STRATA CRITICAL MEDICAL, INC. advertising expense for fiscal 2021 was $1.89M.
| Period end | Advertising Expense 3 month | Advertising Expense 6 month | Advertising Expense 9 month | Advertising Expense 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.71M 10-K · filed 2025-03-13 | |||
| 2023-12-31 | $4.06M 10-K · filed 2025-03-13 | |||
| 2022-12-31 | $4.54M 10-K · filed 2024-03-12 | |||
| 2022-03-31 | $1.34M 10-Q · filed 2022-05-10 | $2.36M derived: sum of 2 quarters · filed 2023-01-10 | $3.16M derived: sum of 3 quarters · filed 2023-01-10 | $3.54M derived: sum of 4 quarters · filed 2023-01-10 |
| 2021-12-31 | $1.02M 8-K · filed 2023-01-10 | $1.82M derived: sum of 2 quarters · filed 2023-01-10 | $2.20M derived: sum of 3 quarters · filed 2023-01-10 | $1.89M 10-K · filed 2023-03-16 |
| 2021-09-30 | $796.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-20 | $1.18M derived: sum of 2 quarters · filed 2021-12-20 | $1.70M derived: sum of 3 quarters · filed 2022-05-10 | $1.89M 10-K · filed 2021-12-20 |
| 2021-06-30 | $383.00K 10-Q · filed 2021-08-16 | $900.00K derived: sum of 2 quarters · filed 2022-05-10 | $1.09M 10-Q · filed 2021-08-16 | $952.00K derived: sum of 4 quarters · filed 2023-01-10 |
| 2021-03-31 | $517.00K 10-Q · filed 2022-05-10 | $710.00K derived: sum of 2 quarters · filed 2023-01-10 | $569.00K derived: sum of 3 quarters · filed 2023-01-10 | $707.00K derived: sum of 4 quarters · filed 2023-01-10 |
| 2020-12-31 | $193.00K 8-K · filed 2023-01-10 | $52.00K derived: sum of 2 quarters · filed 2023-01-10 | $190.00K derived: sum of 3 quarters · filed 2023-01-10 | $1.02M 10-K · filed 2023-03-16 |
| 2020-09-30 | -$141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-20 | -$3.00K derived: sum of 2 quarters · filed 2021-12-20 | $878.00K 10-K · filed 2021-12-20 | |
| 2020-06-30 | $138.00K 10-Q · filed 2021-08-16 | $1.02M 10-Q · filed 2021-08-16 | ||
| 2019-09-30 | $1.78M 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |